Cat. No. | Product name | CAS No. |
DC21582 |
RO 5263397
A highly potent, selective and orally bioavailable trace amine-associated receptor 1 (TRRA1) partial agonist with EC50 of 17 nM, >1,000-fold selectivity over human adrenergic α2A receptor. |
1357266-05-7 |
DC20333 |
Cdc7 inhibitor 7c
A highly potent, selective and time-dependent Cdc7 kinase inhibitor with IC50 of 0.7 nM with slow dissociation property, with 200-fold and >14,000-fold selectivity over CDK2 and ROCK1, respectively. |
1330781-04-8 |
DC22919 |
POL3026
A highly potent, selective beta-hairpin mimetic CXCR4 inhibitor with IC50 of 1.2 nM in Ca2+ flux assay. |
918660-21-6 |
DC22918 |
POL2438
A highly potent, selective beta-hairpin mimetic CXCR4 inhibitor with IC50 of 1.9 nM in Ca2+ flux assay. |
790223-00-6 |
DC22342 |
MK-3207
A highly potent, selective CGRP receptor antagonist with Ki of 21 pM in in vitro binding assay and IC50 of 0.12 nM in cell-based functional assay. |
957118-49-9 |
DC20924 |
CPI-1205
A highly potent, selective EZH2 inhibitor with biochemical IC50 of 2 nM, cellular EC50 of 32 nM. |
1621862-70-1 |
DC20598 |
2-BFI hydrochloride
A highly potent, selective imidazoline I2 receptor agonist with Ki of 9.8 nM, enhances supraspinal morphine analgesia in mice.. |
89196-95-2 |
DC23339 |
NTRC 00660
A highly potent, selective inhibitor of checkpoint kinase TTK/Mps1 with IC50 of 0.6 nM. |
1817791-73-3 |
DC11637 |
MPK-09
A highly potent, selective mutant p53 (R175H, R249S, R273H, R273C) reactivator. |
1431884-83-1 |
DC23478 |
MRS-2365
A highly potent, selective P2Y1 receptor agonist with EC50 of 1.2 nM. |
436847-09-5 |
DC20935 |
CV-6209
A highly potent, selective platelet activating factor (PAF) inhibitor with IC50 of 75 and 170 nM for aggregation inhibition of rabbit and human platelets induced by PAF. |
100488-87-7 |
DC23518 |
PF-470
A highly potent, selective, and efficacious metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator with Ki of 0.9 nM, IC50 of 2.5 nM. |
1539296-45-1 |
DC21658 |
SKI-2852
A highly potent, selective, and orally bioavailable 11β-HSD1 inhibitor with IC50 of 2.9 and 1.6 nM for hHSD1 and mHSD1, respectively. |
1346554-47-9 |
DC20964 |
Razaxaban
A highly potent, selective, and orally bioavailable factor Xa (FXa) inhibitor with Ki of o.19 nM, >5,000-fold selectivity over a series of related serine proteases. |
218298-21-6 |
DC20965 |
Razaxaban hydrochloride
A highly potent, selective, and orally bioavailable factor Xa (FXa) inhibitor with Ki of o.19 nM, >5,000-fold selectivity over a series of related serine proteases. |
405940-76-3 |
DC11936 |
TAK-915
A highly potent, selective, brain-penetrating and orally active phosphodiesterase 2A (PDE2A) inhibitor with IC50 of 0.61 nM. |
1476727-50-0 |
DC23466 |
GRN-529
A highly potent, selective, orally active mGluR5 negative allosteric modulator with Ki of 5.4 nM, IC50 of 3.1 nM. |
1253291-12-1 |
DC11522 |
Imarikiren hydrochloride
A highly potent, selective, orally active renin inhibitor with IC50 of 2.1 nM in hPRA assay. |
1202269-24-6 |
DC23863 |
eCF506
A highly potent, selective, orally available Src family kinase inhibitor with IC50 of <0.5 nM, <0.5 nM and for Src, Yes and Fyn kinases respectively, >950-fold selectivity for Src over ABL. |
1914078-41-3 |
DC11823 |
BMS-929075
A highly potent, selective, orally bioavailable HCV NS5B polymerase inhibitor with IC50 of 9, 4, and 18 nM for GT1a, GT1b, and GT1b-C316N mutant in HCV replicon assay, respectively. |
1217338-97-0 |
DC23972 |
MK-2894 sodium
A highly potent, selective, second generation prostaglandin E2 subtype 4 receptor (EP4) antagonist with Ki of 0.56 nM. |
1006036-88-9 |
DC22972 |
S-17092
A highly potent, specific and cell permeant inhibitor of human proline endopeptidase (PE) with Ki of 1 nM. |
176797-26-5 |